|
|
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Vol. 14, Issue 3, 926-938, March 2003
Department of Molecular Biophysics and Physiology, Rush Medical College, Chicago, Illinois 60612
Submitted September 9, 2002; Revised October 22, 2002; Accepted November 6, 2002| |
ABSTRACT |
|---|
|
|
|---|
Fusion proteins of many viruses, including HIV-1 envelope protein (Env), fold into six-helix bundle structures. Fusion between individual Env-expressing cells and target cells was studied by fluorescence microscopy, and a temperature jump technique, to determine whether folding of Env into a bundle is complete by the time fusion pores have formed. Lowering temperature to 4°C immediately after a pore opened halted pore growth, which quickly resumed when temperature was raised again. HIV gp41-derived peptides that inhibit bundle formation (C34 or N36) caused the cold-arrested pore to quickly and irreversibly close, demonstrating that bundle formation is not complete by the time a pore has formed. In contrast, lowering the temperature to an intermediate value also halted pore growth, but the pore was not closed by the bundle-inhibiting peptides, and it enlarged when temperature was again elevated. This latter result shows that bundle formation is definitely required for the fusion process, but surprisingly, some (if not all) bundle formation occurs after a pore has formed. It is concluded that an essential function of the bundle is to stabilize the pore against collapse and ensure its growth.
| |
INTRODUCTION |
|---|
|
|
|---|
The process of membrane fusion is central to a
diverse range of physiological events (Hernandez et al.,
1996
). The energy required to induce membrane merger is provided by the
conformational changes of the fusion proteins. The initial fusion pore
is a small water-filled passageway that connects two formerly separate
aqueous compartments. The process of fusion, however, is not completed until the pore enlarges sufficiently to accommodate the contents that
must transfer between aqueous compartments for biological function to
proceed. To elucidate the mechanism of membrane fusion, the
correspondence between conformational changes of the fusion proteins
and the lipid rearrangements of pore formation must be identified.
For intracellular fusion in eukaryotic cells, SNARES are the favored
candidate proteins (Jahn and Sudhof, 1999
), although their precise
roles remain controversial (Coorssen et al., 1998
; Mayer,
2001
). In contrast, the proteins that mediate fusion between viral
envelopes and cell membranes have been unambiguously identified for
most known viruses. The fusion proteins of many viral families have
been crystallographically shown to form a trimer of hairpins, a
structure referred to as a six-helix bundle (6HB; Skehel and Wiley,
2000
; Eckert and Kim, 2001
). A six-helix bundle consists of three
N-terminal heptad repeat segments that form a trimeric coiled coil and
three C-terminal helical segments that bind, in antiparallel
orientation, to hydrophobic grooves along the central coiled coil. The
6HB is an extremely stable structure, melting only at temperatures that
are well above the physiologically pertinent one of 37°C (e.g., Lu
et al., 1995
). (A helical bundle motif may also be important
for eukaryotic fusion: the SNARE complex exhibits a thermally stable
helical bundle [Poirier et al., 1998
; Sutton et
al., 1998
].)
The fact that 6HBs are found in many viral fusion proteins clearly
demonstrates that this structure must be critical in the viral fusion
process. The role of the 6HB in fusion has been most extensively
studied for the HIV envelope (Env) glycoprotein. Structural (Ji
et al., 1999
) and mutagenesis (Dubay et al.,
1992
; Cao et al., 1993
; Weng et al., 2000
; Lu
et al., 2001
) studies of the Env fusion subunit, gp41, have
provided strong evidence that the 6HB directly participates in fusion.
Also, synthetic peptides with the amino acid sequences of the N- and
C-terminal heptad repeats of gp41 have been shown to inhibit
Env-mediated membrane fusion and viral infection (Jiang et
al., 1993
; Wild et al., 1994
; Munoz-Barroso et
al., 1998
) by binding to complementary cognate sites on gp41,
preventing 6HB formation (Lu et al., 1995
; Weissenhorn et al., 1997
; Chan and Kim, 1998
; Eckert and Kim, 2001
). A
C-peptide, T20, is currently in phase III of clinical trials as an
antiviral therapy (Kilby et al., 1998
). The N- and
C-peptides are powerful experimental tools for determining the
mechanism by which Env refolding promotes membrane fusion.
In general, the fusion peptides (nonpolar stretches of amino acid
residues) reside near the N-terminal heptad repeats and the membrane
spanning segments reside near the C-terminal repeats. Once a protein
has folded into its 6HB structure, the antiparallel arrangement of N-
and C-terminal segments should bring the fusion peptides and membrane
spanning segments into close proximity (neither of these domains is
part of the crystallized fragments). Because fusion peptides are
thought to insert into target membranes (Durrer et al.,
1996
) and the membrane-spanning segments are located in the viral
envelope, the two membranes should come into close proximity as Env
refolds from its initial structure into the bundle configuration (Weissenhorn et al., 1997
; Chan and Kim, 1998
; Eckert and
Kim, 2001
). Because the bundle is a critical structure, whether
formation of the bundle is also responsible for events subsequent to
membrane approach is central for understanding the fusion mechanism. If the temporal and functional relation between the formation of the
bundle, the formation of the pore, and enlargement of the pore were to
be identified, such understanding would be greatly advanced (Melikyan
et al., 2000b
; Russell et al., 2001
).
The present study addresses whether Env has folded into a 6HB by the time the pore has formed. We took advantage of the temperature-dependence of pore growth and used peptides that block bundle formation to answer this central question. We found that by the time the pore forms, folding of Env into bundles has not been completed: either none of the Env participating in pore formation have yet fully folded into bundles or some have completed their folding, whereas others have not. Further, completion of folding into bundles after pore formation stabilizes the initial pore against collapse. We propose that binding of the inhibitory peptides to a prebundle configuration of Env not only prevents bundle formation, but also causes these Envs to revert to an even earlier, more upstream prebundle configuration.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Reagents
Reagents (including the appropriate reference and original
source) obtained from the NIH Research and Reference Reagent Program, Division of AIDS, NIAID, NIH were as follows:
HeLaT4+ cells (Maddon et al., 1986
)
provided by Dr. Richard Axel; 3T3.T4.CXCR4 cells (Deng et
al., 1997
) provided by Dr. Dan R. Littman; CXCR4 mAb 12G5 (Endres
et al., 1996
) provided by Dr. James Hoxie; and HIV-1 C34
peptide (Chan et al., 1998
) provided by Dr. Peter Kim. The
TF228.1.16 cell line stably expressing HIV-1 Env glycoprotein (BH10
strain) was a kind gift from Dr. Z. Jonak (Smith Kline Beecham, Philadelphia, PA). We were also generously provided with the
gp41-derived peptides C34 and N36 by Dr. Min Lu (Cornell Medical
School, New York). We purchased the peptide T22, a CXCR4 antagonist,
from Bachem Bioscience (King of Prussia, PA); Q4120, an mAb against CD4, and bovine serum albumin (BSA) from Sigma Chemical Co. (St. Louis,
MO); lauroyl-lysophosphatidylcholine (LPC) from Avanti Polar Lipids
(Alabaster, AL); and the fluorescent dyes calcein AM and CMAC
(7-amino-4-chloromethylcoumarin) from Molecular Probes (Eugene, OR).
Cell Maintenance, Transfection, and Labeling
TF228.1.16 cells were cultivated in RPMI-1640 medium (GIBCO BRL,
Gaithersburg, MD) supplemented with 10% Cosmic Calf serum (Hyclone
Laboratories, Logan, UT). HeLaT4+ cells that
stably express CD4 were grown in DMEM supplemented with 10% Cosmic
Calf serum with 0.5 mg/ml G418, and 3T3.T4.CXCR4 cells that stably
express CD4 and CXCR4 were grown in the same medium, but without G418.
CXCR4 and/or CD4 were transiently expressed with pCDNA3 plasmids
(kindly provided by Dr. Robert Doms, University of Pennsylvania) in
HeLa cells (ATCC, Rockville, MD) grown in DMEM supplemented with 10%
fetal calf serum. The HeLaMonster reagent (Panvera, Madison, WI) was
used for transfection according to the manufacturer's instructions.
Cells were used for experiments ~42 h post transfection. The HIV-1
Env-expressing (effector) cells were loaded with 0.4 µM calcein AM
per 106 cells and, when required, the
CD4+/CXCR4+ cells (target)
were loaded with 20 µM CMAC per 106 cells, as
described (Melikyan et al., 2000b
).
Flow Cytometry
Relative expression levels of CD4 on cell surfaces were
determined by incubating HeLaT4+ cells,
3T3.T4.CXCR4 cells or transfected HeLa cells with saturating concentrations of the antibody Q4120. Similarly, relative expression levels of CXCR4 were determined by using the antibody 12G5. In both
cases, these procedures were followed by binding goat anti-mouse FITC-labeled IgG (Southern Biotech, Birmingham, AL), as previously described (Melikyan et al., 1999
). Cells were analyzed on an
ORTHO Cytoron Absolute flow cytometer (Ortho Diagnostic Systems,
Raritan, NJ).
Fusion Experiments
The fraction of TF228 and HeLaT4+ (or
other target) cells that fuse at 37°C (usually 50-60%) was
quantified as the number of cell pairs labeled by both calcein and
CMAC, normalized by the total number of effector-target (E/T) cell
pairs. In the present study, however, we relied primarily on
monitoring, in real-time, calcein transfer between the individual
effector and target cell pairs using fluorescence videomicroscopy
(Melikyan et al., 2000a
). To synchronize the fusion event
better than occurs by maintaining 37°C, E/T cells were preincubated
at 23°C for 3 h. This procedure has been shown to kinetically
advance the HIV Env-mediated fusion process, so that fusion is rapidly
induced when temperature is raised to 37°C (Melikyan et
al., 2000a
). All experiments were recorded on S-VHS format
videotape, digitizing images with a frame grabber (Matrox Meteor-2,
8-bit resolution), and analyzing dye spread with custom-written
software (Markosyan et al., 2000
). Dye transfer was
quantified by drawing regions of interest encompassing the target and
effector cells and measuring the average fluorescence intensity of that
region over the course of time (Markosyan et al., 2000
).
To initiate and then quickly arrest a small fusion pore, we used a
temperature-jump protocol described in detail elsewhere (Melikyan
et al., 2000a
, 2000b
). Briefly, the experimental chamber, with bottom made of heat-absorbing glass, was mounted in a fluorescence microscope (Axiovert 100A; Carl Zeiss, Thornwood, NY). The solution bathing the cells was maintained at 4°C by mounting the chamber within a Peltier-based temperature-controlled holder (20/20 Technology, Wilmington, NC). Selected E/T cells were irradiated with an infrared laser diode to locally increase temperature to 37°C. The laser was
turned off immediately after a detectable amount of calcein moved into
the target cell, allowing the temperature to drop back to that of the
surrounding bath, 4°C, within ~10 s through passive heat exchange.
Monitoring the Dynamics of Fusion Pores by Fluorescent Dye Redistribution
The rate of aqueous dye transfer between cells increases with
the diameter of the pore lumen. The rate of accumulation of calcein
into the target cell (dCt/dt)
and the rate of its depletion from the effector cell
(
dCe/dt) at any time,
t, are proportional to the permeability of the pore at that
time, P(t), according to
|
(1) |
Ct(t)) is the difference in dye
concentration across the pore at the time t. The function
Q(t) corrects for the diffusion coefficient of
the dye as a function of temperature; we used
Q(t) because the temperature changes were not
instantaneous upon turning the laser on and off. We assumed the
diffusion coefficient increases ~1.3 for every increase of 10°C
(i.e., Q10 ~ 1.3), yielding Q(t) = 1 + 0.03(T0
T
)[1
exp(
bt)].
T0
T
is the steady-state difference in
temperature before and after the jump and the time constant,
b, for temperature changes was obtained by fitting, with a
single exponential, the measured time course of the temperature changes
(unpublished data). For the fluorescence intensity to be a
reliable measure of dye concentration, it is necessary that the
fluorescence of the dye not be quenched and that the video camera
(Stanford Photonics model from Solamere Technology, Salt Lake City, UT)
output vary linearly with incident intensity. We validated the two
requirements. For the first, we treated effector cells with saponin to
release aqueous dye. If the dye was quenched, there would have been a
transient increase in fluorescence as the dye diluted. But there was
not. The linearity of the camera output with incident intensity was
confirmed by placing neutral density filters in the excitation pathway
of the microscope. The average fluorescence intensities of effector
(Fe(t)) and target
(Ft(t)) cells are therefore
proportional to Ce(t) and Ct(t), respectively.
We often improved the sensitivity of dye transfer measurements by
increasing the gain of the video camera to the point that the
fluorescence of the effector cells saturated the camera's output
(maximum 256 brightness units). As a consequence, after calcein had
fully redistributed between cells, the fluorescence intensities were
within the range of 150-200 brightness units. The pore permeability
was calculated from the fluorescence increments of a target cell
according to
|
(2) |
is the mean
fluorescence intensity of the target cell after complete dye
redistribution. Eq. (2) assumes that the cytoplasmic dye does not leak
into the extracellular solution and that it completely equilibrates
between the cells at infinite time, so that
Ct
= 1/2Ce(0). Equilibration was often
not perfect: a small immobile fraction of calcein (<20%) was often
retained in the effector cell, as established by lysing individual
calcein-loaded cells with saponin (unpublished data). The occurrence of
an immobile fraction of calcein would introduce a systematic error when
using Eq. (2) to estimate pore permeability when it was large. Because
we are primarily concerned with the evolution of a pore while it is
small, such errors were inconsequential. We verified that the pore
permeability calculated by Eq. (2) was in fact close to that obtained
by Eq. (1) when gain settings of the camera were sufficiently low that
they did not saturate the camera output (unpublished data).
| |
RESULTS |
|---|
|
|
|---|
Dynamics of Fusion Pore Size Can Be Monitored from the Redistribution of Cytoplasmic Aqueous Dyes
HIV Env-expressing effector (designated "E") cells loaded with
calcein were bound to target ("T") HeLaT4+
cells (Figure 1A). The E/T cells were
preincubated at 23°C for 3 h. Cells so treated proceed toward
fusion but will not fuse at this temperature, stopping at what is
referred to as a temperature-arrested stage (TAS) (Melikyan et
al., 2000b
). When temperature is raised to 37°C at this stage,
fusion will occur within a few minutes, a much quicker rate than for
cells that are bound and allowed to fuse at a constant 37°C. TAS is a
stable state: it does not revert to a less advanced state of fusion
when temperature is lowered to 4°C. After establishing TAS, the E/T
cell pairs were placed in an experimental chamber maintained at 4°C.
Fusion was triggered by quickly and locally raising temperature to
37°C by illuminating cells with an IR laser diode.
|
On fusion, calcein was observed to move from the effector to the target
cell (Figure 1, C and D). The average fluorescence intensities within
the target and effector cells as a function of time were quantified
(Figure 1, bottom panel, thick solid lines) and this allowed us to
estimate, by a straightforward method, pore permeability throughout the
time course of pore evolution. The dye continued to redistribute until
the same intensities were reached in the two cells (image D and
equality of fluorescence in bottom panel), showing that a fusion pore
was maintained. Leakage of calcein into the external medium was usually
small, as shown by the constancy of the sum of fluorescence intensities
of the effector and target cells (thin line). The total pore
permeability continuously increased over the ~1-min time period it
took for the dye to fully redistribute (Figure 1, bottom panel,
).
This pattern of permeability increase is in agreement with prior
electrophysiological measurements and demonstrates quick enlargement of
fusion pores induced by HIV Env (Melikyan et al., 2000b
).
Although our method of determining the evolution of fusion pore size
based on changes in fluorescence intensities over time is not as direct
as electrical measures of pore size, it can be used for the
wide-ranging manipulations of this study whereas, as a practical
matter, electrical measures cannot.
Pore Growth Can Be Arrested by Lowering Temperature and Restored by Raising Temperature
Immediately after the onset of calcein redistribution at 37°C,
we shut off the IR laser and the temperature of the E/T cells dropped
back to the temperature of the surrounding bath (4°C) in <10 s. The
rate of calcein accumulation in the target cell (Figure
2A, fluorescence intensity shown by the
noisy solid curve) decreased upon dropping temperature to 4°C. The
pore permeability (
), calculated from the fluorescence trace (using
Eq. (2)), ceased to increase shortly after lowering temperature to
4°C and thereafter slowly decreased over the course of several
minutes. The low temperature thus not only prevents further growth of
the pore, it causes pore shrinkage. On raising the temperature back to
37°C, the rate of calcein transfer rapidly increased because the pore
immediately enlarged (nearly vertical line). Thus by maintaining
4°C, small pores can be sustained for several minutes, allowing
them to be studied. But if temperature was maintained at 4°C for more
than ~15 min, the pores irreversibly closed, as determined by the
absence of additional dye spread upon raising temperature to 37°C
(unpublished data).
|
It was important to establish that the same pore was followed
throughout an experiment as temperature was varied. To rule out the
possibility that a new pore formed upon raising temperature, we
performed two types of experiments. In the first, we raised the
temperature to 23°C instead of 37°C (Figure 2B). This protocol resulted in an immediate augmentation of dye spread (Figure 2B, noisy
solid data curve): quantitatively the pore quickly enlarged (nearly
vertical increase in pore permeability,
). Because fusion pores do
not form at 23°C for the E/T cells used here (Melikyan et
al., 2000b
), the enhanced calcein movement at 23°C must be due
to widening of the pore whose size was arrested by 4°C (the "cold-arrested pore"). In fact, the rate of fluorescence increase was so enhanced at 23°C, compared with the initial rate at 37°C, that the pore must have progressed in some way during its time at
4°C, even though pore permeability did not increase at this low
temperature. In the second set of experiments, we measured the times
between raising the temperature of E/T pairs at TAS to 37°C and the
observation of dye spread. The kinetics of pore formation after raising
temperature to 37°C at TAS (Figure 2C,
) was significantly slower
than the kinetics of augmentation of dye spread upon raising
temperature of the cold-arrested pore (
). We do not have a measure
for the actual number of pores that form between cells, but we can
describe the situation as if it were one pore connecting the cells.
Although we cannot determine how many pores existed before temperature
was lowered, we can unambiguously determine that they have all closed
once there is a cessation of dye transfer. Although it would obviously
be informative to know how many pores were present at every point in an
experiment, we can determine whether a manipulation will reliably cause
the elimination of all pores.
Peptides that Inhibit Formation of a Six-helix Bundle Can Cause Quick and Irreversible Closure of a Cold-arrested Pore
During the normal course of fusion, its various states are so transitory that they cannot be characterized. Characterization becomes possible, however, by arresting states. Peptides that inhibit 6HB formation can be added to the cold-arrested fusion pore to determine whether bundle formation has been completed at this point. We anticipated that if bundles had not formed, subsequent bundle formation would be central to pore enlargement and therefore that the peptides would inhibit pore growth when temperature is elevated.
After creating the cold-arrested pores, we added the peptides C34 or
N36 and allowed them to bind to their cognate sites on gp41 (C34 to the
N-terminal coiled coil and N36 to the C-terminal heptad repeat) for
~5 min before raising the temperature to 37°C. Strikingly, both C34
(Figure 3A) and N36 (Figure 3B) quickly
stopped calcein transfer through the pores, showing that these pores
either closed entirely or shrank to sizes too small to accommodate
calcein. It is much more likely that the pores closed, and did so
irreversibly, because raising the temperature to 37°C after
incubation with the peptides did not induce any additional dye transfer
(Figure 3, A and B). Even when C34 was allowed to bind for only 3 min and unbound peptide was removed by washing, raising temperature to
37°C failed to promote pore reopening in 3 of 4 experiments (unpublished data). Thus the slow spontaneous closure of the
cold-arrested pores (Figure 2A) was drastically accelerated by the
presence of C34 and N36. These experiments show that formation of 6HBs is not completed by the time the pore forms. Clearly, some (perhaps even all) of the gp41 that participate in pore evolution have not yet
folded into a bundle by the time a pore forms and these copies of gp41
are somehow critical for maintaining a pore in an open state. We refer
to pores that close in the presence of the inhibitory peptides as
"labile." The pores defined as labile by this criterion are also
the ones that shrink and close within 15 min at 4°C.
|
To determine whether interactions between chemokine receptors and Env
play a role in pore evolution, we added a high concentration of the
peptide T22 (which is a CXCR4 antagonist that greatly reduces pore
formation if added at TAS; Melikyan et al., 2000b
) to the cold-arrested pore; pore behavior was not affected (Figure 3C). Thus,
whereas formation of a pore from TAS still requires gp120-chemokine receptor interactions, once a pore has formed these interactions are no
longer relevant for either maintenance or growth of pores. The absence
of an effect by T22 implies that pore stabilization and enlargement do
not require additional Env proteins to be activated by binding to
coreceptors. This absence of an effect when adding a peptide that does
not target gp41 also serves as a control; it shows that the inhibitory
actions of C34 and N36 are specific: they cause pore closure because
they prevented formation of a 6HB.
Not only was pore dynamics independent of chemokine receptor activity,
but it was independent of lipid composition as well: LPC, as a lipid
component of membrane bilayers, inhibits Env-induced cell-cell fusion
when added before or at TAS (Melikyan et al., 2000b
).
However, when LPC was added to cells connected by cold-arrested pores,
neither pore stability at 4°C nor subsequent pore growth at 37°C
was noticeably affected (Figure 3D). This result suggest that fusion
proteins, rather than lipids, maintain the pore in an open state.
In general, individual fusion pores grow in a similar manner, but that
growth is quantitatively variable. To characterize the response of a
pore to a treatment, we calculated the average pore permeability
profile (Figure 4B) from multiple
experiments that track calcein transfer over time (Figure 4A). In the
control experiments, calcein continued to accumulate within target
cells (Figure 4A,
) for at least 4-5 min at 4°C, showing that
these fusion pores remained open. But dye transfer was fully blocked soon after adding either C34 (
) or N36 (
). The averaged pore permeability calculated from the individual fluorescence profiles clearly revealed a relatively stable (although slowly declining) pore
size in the absence of inhibitory peptides (Figure 4B,
). But in the
presence of C34 (circles) or N36 (triangles), the average pore closed
rapidly and irreversibly, within about 1 min.
|
At High Surface Density of Coreceptors, Pores Are Resistant to Blockers of 6HB Formation
Assuming 6HB formation is irreversible (Chen et al.,
1995
; Kliger and Shai, 2000
), it is clear that at least some gp41
trimers that participate in maintaining the cold-arrested pore are not yet in 6HBs at this stage because the addition, at this point, of
peptides that prevent bundle formation can cause pore closure. The
number of gp41 trimers that can undergo the conformational changes
necessary for bundle formation should depend on the density of
receptors and coreceptors in the target membrane. The standard target
cells HeLaT4+ that were used in the above
experiments express a high level of the receptor CD4, but a low level
of the coreceptor CXCR4 (Maddon et al., 1986
). We therefore
also used target cells that express high levels of both CD4 and CXCR4
to allow more extensive activation of Env. For these experiments we
either transiently expressed CD4 and CXCR4 in HeLa cells (the parental
cells used to produce HeLaT4+) or we used a
stable 3T3 cell line, 3T3.T4.CXCR4 (Deng et al., 1997
). By
expressing CD4 and CXCR4 in HeLa cells (which we denote HeLa/CD4/X4) we
were able to keep aspects of the target membrane (such as membrane
mechanics) constant yet vary receptor and coreceptor density. The
relative expression levels of CD4 and coreceptor were assessed by FACS
analysis for both HeLa/CD4/X4 and HeLaT4+ cells
(Table 1). As expected, both the
mock-transfected HeLa and HeLaT4+ cells expressed
comparable low levels of CXCR4. The HeLa/CD4/X4 cells, in contrast,
expressed much higher levels of coreceptor and the levels of CD4 were
made comparable to those of HeLaT4+ cells.
|
For the HeLa/CD4/X4 cells, the enlargement of fusion pores was
reversibly arrested by 4°C, using the same protocols as those followed for the HeLaT4+ cells. Although the
pores with HeLaT4+ cells rapidly closed upon
addition of C34, here the cold-arrested pores did not close even in the
presence of high concentrations of C34 (up to 900 nM), and they readily
enlarged when the temperature was raised from 4 to 37°C (Figure
5, A and B,
). In contrast, for HeLa
cells transfected only with CD4 (HeLa/CD4 cells), pores closed in the
presence of C34 at 4°C and remained close when the temperature was
elevated to 37°C (Figure 5, A and B,
). This behavior, the same as
that observed for HeLaT4+ cells as target, shows
that for low density of CXCR4 (and high density of CD4), the pores can
be closed by C34, but those that form for a high level of CXCR4 in the
target cell cannot be so closed. We refer to pores that remain open in
the presence of the 6HB peptides as "robust." The calculated
average pore permeability at 4°C quantitatively demonstrates that
cells expressing a high level of CXCR4 exhibit relatively stable pore
sizes at 4°C, independent of whether C34 peptide was present (Figure
5C,
) or not present (
). But for target cells expressing a low
level of coreceptor, all pores quickly closed at 4°C in the presence
of C34 peptide. This was demonstrated by the fact that the average
total permeability decreased to zero (
).
|
We tested the generality of our finding that coreceptor density
controlled pore properties by carrying out experiments similar to those
described for a very different target cell, 3T3.T4.CXCR4. As expected
for target cells that express a high density of receptors and
coreceptors (Table 1), the cold-arrested pores remained open in the
presence of C34 and enlarged when the temperature was raised to 37°C
(Figure 6A,
). The calculated average
permeability of the arrested pore shows that the addition of C34 did
not cause pore closure (Figure 6B, open circles for C34, filled circles for no peptide). Thus, regardless of the specific cell line, a high
density of receptor and coreceptor in the target cells ensures that the
pore that forms is resistant to peptides that inhibit formation of the
6HB.
|
Bundles Do Not Form before Membrane Merger at High as well as Low Chemokine Receptor Densities
We previously showed that for HeLaT4+ cells
(which have low CXCR4 densities), bundles do not form before pore
opening (Melikyan et al., 2000b
). Because the inhibitory
peptides had no effect on the robust pores that formed for target cells
expressing a high density of coreceptor, it was possible that in this
case bundles had formed before membrane merger. We tested this for 3T3.T4.CXCR4 cells using the same strategy we used previously: We
created TAS and added LPC to the E/T cell pairs. The LPC, as a lipid
component within the membranes (Chernomordik et al., 1995
), blocked fusion upon subsequent exposure to 37°C. After the
temperature was lowered to 23°C, the LPC in solution and within the
membrane was removed by washing, and fusion still did not occur (Figure 7, second bar). The intermediate of
fusion created by this procedure is referred to as a lipid-arrested
stage (LAS; Melikyan et al., 2000b
). If at this point,
temperature is again raised to 37°C, the full extent of fusion was
observed (last bar), demonstrating that the effect of LPC was
reversible. If before raising temperature at LAS, C34 (third bar) or
N36 (fourth bar) was added, fusion was suppressed, showing that bundles
had not formed at the point of LAS and that, as in the case of low
chemokine receptor density, bundle formation requires membrane merger.
We have thus now shown that for high, as well as low, chemokine
receptor density, bundle formation requires membrane merger.
|
Labile Pores Are Converted to Robust Pores when Arrested at an Intermediate Temperature
For pores that form at 37°C with a low density of CXCR4 in the
target membrane, not all gp41 participating in pore maintenance has
folded into 6HBs, as judged by the ability of C34 and N36 to close
pores at 4°C. We have shown that for high chemokine receptor densities, the fusion pore reaches a stage in which it is unaffected by
peptides that prevent bundle formation. But we had not yet shown that
this stage is reached for low densities of chemokine receptors. We
therefore sought, for low chemokine receptor density, a temperature
that prevented pore enlargement yet allowed the labile pore to convert
to a robust pore. We used HeLaT4+ cells and
lowered temperature from 37 to 15°C (instead of 4°C), once a pore
formed. These pores did not close after addition of C34. This held true
in records of individual experiments (Figure 8A) and in averaging from many
experiments (Figure 8B). The labile pore therefore evolves into a
robust pore if temperature is not too low. As expected for a
robust pore, the pores arrested at 15°C enlarged when temperature was
increased to 37°C in the presence of C34 (Figure 8A). In 10 of 14 experiments in which a high concentration (150 nM) of C34 was added at
15°C, the pores fully enlarged. Clearly, for low densities of
chemokine receptors, at the time a pore initially forms, not all gp41
trimers engaged in the process have folded into 6HBs; at least some
trimers must fold into bundles subsequent to pore formation. High
densities of chemokine receptors in the target cell should better
facilitate synchronous formation of 6HBs and, in fact, caused a pore to
quickly become insensitive to C34. These results suggest that the
window of time during which the pore evolves from labile to robust is
highly dependent upon temperature and chemokine receptor density. The
sensitivity of pore evolution to temperature and to peptides
immediately suggests that the fate of the initial pore is basically
under the control of fusion proteins rather than membrane lipids. Our
results strongly indicate that the conversion of a labile pore to a
robust pore is still not spontaneous. Rather, fusion proteins must
sustain the pore, and free energy released by protein conformational
changes subsequent to pore formation is utilized to stabilize the pore in an open state, allowing it to further enlarge.
|
| |
DISCUSSION |
|---|
|
|
|---|
It has long been realized that the 6HB must be critical to fusion
because ectodomains of many viral fusion proteins, when in solution,
fold into bundles, and because peptides that block bundle formation
have been shown to prevent fusion (Skehel and Wiley, 2000
; Eckert and
Kim, 2001
). Experiments in which peptides have been used to prevent
fusion have only shown that bundles have not yet formed at the point of
peptide addition (Munoz-Barroso et al., 1998
; Melikyan
et al., 2000b
; Gallo et al., 2001
; Russell et al., 2001
; Golding et al., 2002
). They have
not explicitly provided an experimental demonstration that bundles do
form during the fusion process. We have now provided that demonstration
by showing the conversion of a fusion pore from one that can be closed by peptides (a labile pore) to one that cannot be closed (a robust pore). Furthermore, in the present study, we have made the surprising discovery that bundle formation plays a role subsequent to pore formation. Both the time of formation (post pore opening) and the role
of the bundle (to maintain the pore in an open state) were unexpected
findings. It is so widely believed that bundle formation is a requisite
for pore formation that it is almost assumed that this has been
experimentally verified. But, in fact, it has not. Based on our own
acceptance that bundles are required for fusion pore opening, when we
demonstrated that 6HBs do not form before membrane merger, we had
concluded that the pore and the bundle form simultaneously (Melikyan
et al., 2000b
). It remains possible that some bundles
participate in pore formation, whereas others act subsequently, but we
now have hard data that bundle formation stabilizes the open pore. If
the common expectation that bundles are necessary for pore formation is
not correct, then the configurations of Env that induce the fusion pore
remain to be identified. It would also mean that peptides, such as C34, that block formation of 6HBs, inhibit fusion by affecting
conformational changes upstream of the bundle.
It is known that the early pore of intracellular fusion is a labile
structure that can still close, and that its growth is controlled by
protein (Jahn and Sudhof, 1999
). Because there are structural
similarities between the SNARE complex and viral fusion proteins (e.g.,
they both contain helical bundles), an understanding of six-helix
bundle folding and labile-to-robust pore conversion could provide a
general conceptual framework for aspects of intracellular fusion.
Env Folds into Six-helix Bundles More Readily after Pore Formation
When fusion peptides and membrane-spanning segments of Env are inserted in opposite membranes, the ability to form a bundle will be much more constrained than bundle formation of isolated ectodomains in solution. Bundle formation by membrane-anchored gp41 is made even more difficult by the threefold symmetry of Env: The three C-terminal heptad repeats must somehow separate from each other and move so that each fits into one of the three grooves of the N-terminal trimeric coiled coil in an antiparallel orientation. The relatively small number of amino acid residues (~20) between the repeats and the membrane-spanning domains should limit the possible ways the repeat segments can move. If the three C-terminal heptad repeats bind into the grooves sequentially, the movement of each repeat into a groove would affect the binding of the subsequent ones. One would expect that because fusion peptides and membrane-spanning domains must come into proximity for bundles to form, Env should be able to fold into a bundle only at the site of a pore. The membrane continuity created by a pore would facilitate the movement of membrane-spanning domains that is needed for them to fold in a threefold symmetric manner around the central coiled-coil.
It is thought that multiple copies of Env act in concert to form the
initial pore. One could imagine that additional Envs are recruited into
the region where the pore has formed as a means of ensuring pore
stabilization. There is, however, no experimental evidence to support
this and some evidence to suggest that no recruitment takes place: the
permeabilities (and hence diameters) of arrested labile pores slowly
decreased with time. If additional Envs had been recruited into the
labile pore, one would expect the pore to enlarge or at least to
maintain itself. But some changes must have occurred during
arrest
possibly altered interactions between Env trimers, formation or
merger of cholesterol/sphingolipid rafts, or other phase separation at
4°C, since the pore enlarged much more rapidly after raising
temperature (to 23 or 37°C) than when temperature was maintained at
37°C. A mechanistic explanation that we presently favor for the more
rapid enlargement after arrest is that lipid leaves the pore during the
arrest. This would account for smaller pore lumens and lead to greater
density of gp41 at the site of the pore, without recruiting additional
protein. A higher density of gp41 would facilitate any cooperative
actions between copies of gp41 that are part of pore enlargement.
We have previously shown that if membrane merger is prevented by
incorporating LPC into membranes, addition of the peptides C34 or N36
inhibits fusion when the LPC is removed. This indicates that formation
of a 6HB requires membrane merger (Melikyan et al., 2000b
).
If it were assumed that formation of a pore requires Env to fold into
bundles, then it would follow that pore formation and bundle formation
must be occurring simultaneously. But in the present study we have
found that inhibitory peptides can cause the pore to close. The fact
that these peptides have any effect at all at this stage signifies that
after a pore has opened, at least some of the relevant Envs remain in a
prebundle state. It also means that some of these prebundle
configurations must, in some way, be helping to maintain the pore in an
open state, and because the pore closes quickly after adding peptide,
peptide binding must be altering the prebundle configurations.
Binding of Inhibitory Peptides Reduces Late Prebundle Conformations of Env
There are undoubtedly many conformations before the six-helix
bundle in which the heptad repeats of Env are exposed. We separate states upstream of the bundle into two classes
"early" and
"late" prebundle configurations (Figure
9). We define an early prebundle configuration as activated Env in which none of the C-segment heptad
repeats are bound into a groove of the coiled coil, and a late
prebundle configuration as a structure in which one or two of the three
C-segment heptad repeats have bound. Once the bundle has formed, it
does not, as a practical matter, convert back to a prebundle
configuration (Chen et al., 1995
; Kliger and Shai, 2000
;
Markosyan et al., 2002
). Because early and late prebundle states are not expected to be as stable as the final six-helix bundle
configuration (in which all three C-segment heptad repeats are bound
within the grooves), we assume that transitions between early and late
prebundles are reversible. That is, the bound C-segments can dissociate
from the coiled coil before completion of the threefold symmetric 6HB.
The inhibitory peptides can block bundle formation and inhibit fusion
by binding to the heptad repeats of either early or late bundles.
|
How could the inhibitory peptides alter the prebundle configurations to
cause pore closure? Binding of C34 into a groove of the coiled coil
would prevent binding of the C-terminal segments of gp41 into that
groove; binding of N36 (which naturally oligomerizes into its own
coiled coils) to gp41 C-terminal segments would similarly prevent these
segments from fitting into the grooves of the gp41 coiled coil. Binding
of peptides to early prebundles would deter progression to late
prebundles. In contrast, binding of peptides to late prebundles would
not hinder the dissociation of any of the previously bound C-segments
of gp41. This means that the transition from early to late prebundles
would be reduced, but transition from late to early prebundles would be
unaffected. Peptide binding would thereby cause a buildup of early
prebundle configurations at the expense of the late prebundles. Because
the inhibitory peptides can cause pore closure, we propose, as a
central conjecture, that Env in a late prebundle configuration
stabilizes the pore against closure, but an early prebundle does not
provide this support. Because a late prebundle can reverse into an
early prebundle, the pore is not permanently open
that is,
robust
until folding into a 6HB is complete. If lowering temperature
to 4°C reduced the folding of Env into a bundle to a greater extent
than it reduced transitions between early and late prebundles, more
late prebundles would convert back to early prebundles. According to
our central conjecture that it is the late prebundle (and bundle) that
stabilizes the pore, we would expect the pore to eventually close at
4°C.
The Role of Bundle Formation
The simplest explanation of all data would then be that
transitions into late prebundle states are responsible for pore
formation, and the actual bundles do not occur until after a pore
forms. In this scenario, when Env does fold into a bundle, it converts a labile pore into a robust pore. In an alternative model, some trimers
of Env fold into bundles simultaneously with the formation of the
initial pore. The resulting membrane continuity allows additional
trimers to fold into bundles, which stabilizes the pore. In this latter
model, not all Env is in the same configuration when the pore initially
forms. In both models, once the pore is robust, all relevant copies of
Env have folded into bundles. In contrast to our conclusion that the
bundle does not form before the pore, it has been argued that 6HBs form
before pore formation and are responsible for fusion on the evidence
that antibodies raised against 6HBs can inhibit fusion (Golding
et al., 2002
). But these antibodies recognize Env that has
been activated by soluble CD4 alone (de Rosny et al., 2001
).
Therefore the antigenic sites recognized by the antibodies may be
exposed by prebundle configurations, and if so, the inhibition of
fusion by the antibodies would be expected according to either of our
models described above.
The Initial Pore Is Labile
In actual infection, the cells that are targets for HIV-1 have a
low density of chemokine receptors compared with transfected cells (Lee
et al., 1999
; Tokunaga et al., 2001
), and thus
experiments using cells with low densities of coreceptor as target
might best model the physiological situation. At low densities, the
addition of C34 or N36 induced rapid closure of the pore arrested at
4°C. But at 15°C, the pore quickly (<30 s) evolved into a robust
one and the addition of the peptides was of no consequence. We conclude that at 15°C, Env folds into six-helix bundles at the site of a pore
before peptides can be bound to Env. Before pore formation, however,
bundles do not form at 15°C, as evidenced by the ability of the
peptides to inhibit fusion when added at TAS (Melikyan et
al., 2000b
). We have thus been able to experimentally verify the
expectation that bundles form more readily after membrane merger than
before. The higher the density of chemokine receptors, the greater the
number of Env trimers that become activated. At high chemokine receptor
densities, pores were robust by the time (5-10 s) temperature could be
lowered from 37 to 4°C. The greater percentage of Env that was
activated would account for this effect.
We suggest that the initial pore is always labile, no matter what the
temperature or chemokine receptor density. Biologically, this would
mean that when the pore first forms at 37°C, not all (perhaps none)
of the gp41 have yet folded into bundles at the site. A higher peptide
concentration is required to close labile pores (e.g., ~50 nM of C34)
(unpublished data) than is needed to prevent their formation (e.g.,
~15 nM of C34) (Melikyan et al., 2000b
). This provides
more experimental validation for the concept that bundle formation is
made easier by the membrane continuity provided by the fusion pore. The
greater amount of peptide required to close pores than to prevent their
opening indicates that multiple copies of Env act in a more concerted
manner to create a pore than to ensure that it remains open. Conditions
that facilitate folding of Env into a late prebundle will obviously
increase the likelihood for bundle formation and creation of a robust
pore. Thus initial pores readily become robust at high temperature or at high chemokine receptor densities. Labile pores remain small. Once a
fusion pore becomes robust, it can enlarge if temperature is not too low.
Two central questions in the field of viral membrane fusion are: At what point in the fusion process do 6HBs form? and What are the roles of bundles? In this article we have addressed and answered some core aspects of these questions. By quickly lowering temperature after pore formation, we were able to identify a point of bundle formation as occurring between the time the pore forms and the time it becomes robust. The membrane continuity created by a fusion pore facilitates the formation of 6HBs. In our model, binding of inhibitory peptides to prebundle structures prevents the late prebundles from folding into bundles and instead causes them to revert back to early prebundles (Figure 9). The copies of Env that are in late prebundle configurations and in 6HBs serve as buttresses that support the walls of the pore. But reversion of late prebundles removes buttresses and the pore collapses. Only the bundle configuration is stable and so the pore is not robust until all the relevant Envs fold into bundles. In viral infection, late prebundles convert to bundles, an irreversible step that permanently supports the wall of the pore so that it does not close. Once the pore is robust, it is committed to enlarge to sizes that permit passage of the viral nucleocapsid.
| |
ACKNOWLEDGMENTS |
|---|
We thank Sofya Brener for excellent technical assistance. We appreciate the critical reading of this manuscript and helpful discussions with Dr. Leonid Chernomordik. We thank the AIDS Research and Reference Reagent Program, Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH) for providing HeLaT4+ and 3T3.T4.CXCR4 cells, C34 peptide, and 12G5 MAb; Dr. Min Lu for C34 and N36; and Dr. Robert Doms for CD4- and CXCR4-expressing plasmids. This work was supported by National Institutes of Health grants GM-27367 and GM-54787.
| |
FOOTNOTES |
|---|
* Corresponding author. E-mail address: gmelikia{at}rush.edu.
Article published online ahead of print. Mol. Biol. Cell 10.1091/mbc.E02-09-0573. Article and publication date are at www.molbiolcell.org/cgi/doi/10.1091/mbc.E02-09-0573.
| |
ABBREVIATIONS |
|---|
Abbreviations used: 6HB, six-helix bundle; C34, a 34 residue-long C-terminal peptide from the HIV-1 gp41 ectodomain; E/T, effector and target cells in contact; LAS, lipid-arrested stage of fusion; LPC, lyso-phosphatidylcholine; Env, HIV envelope protein; N36, a 36-residue-long N-terminal peptide from the HIV-1 gp41 ectodomain; TAS, temperature-arrested stage of fusion.
| |
REFERENCES |
|---|
|
|
|---|